Summary
This article discusses the initial 52-week data from the COMET trial which showed that etanercept in combination with methotrexate (MTX) was superior to MTX alone in providing clinical remission, radiographic non-progression, and normalized function.
- rheumatoid arthritis clinical trials
- © 2008 MD Conference Express